PRIMAEGISresearch
← Screener
SANSERA

SANSERA

Auto Ancillaries/ 1 document · covered since Apr 2026
Latest view
as of 3 Apr 2026 · not a recommendation

Evidence timeline

What management said

from NSE earnings-call filings · extracted, not interpreted
roe 11.1%
We also see an improvement in our return ratios with ROCE at 18.0% as against 16.2% in FY '25 and ROE at 11.1% against 10.5% during last year.
Call 28-May-2026 · transcript PDF

Outlook, as stated

We had a good October, we are looking at good November, and a decent December, which means that the momentum that we have seen in the Q2 would continue into Q3 and Q4, which would result into at least company achieving, if not the full teens, so very close to the teens that we are targeting.

They seems to be -- in fact, the more concern, what we understood was on -- RVC, which is residual value content, which is currently I think is at 65% on the USMCA region, which means that all the value addition that they expect on a vehicle level to achieve 65% from the USMCA region.

Currently, whatever visibility that we have, which are on the confirmed programs, which are either get already under manufacturing or under development, if I add the exact visibility, up to FY30, our overall cumulative execution would be as of now stands at close to Rs.4,000 crores.

4.25 concrete references per 100 words spoken — counts, currency, units and named periods, not adjectives

Chart exhibits

as drawn · not updated since

No forward scenario

the call carried no figure that bridges to earnings growth.

Price chart

260 sessions to 31 Jul 2026 · daily close · our own broker data
2000 3000 Jul Sep Nov 2026 Mar May Jul vol 3346.9
14 Jul 2025 → 31 Jul 2026 low ₹1237.0 · high ₹3346.9 · last ₹3346.9 · 145.6% over the window close 50-DMA 200-DMA